BridgeBio Pharma, Inc. (BBIO)
65.72
+0.40
(+0.61%)
USD |
NASDAQ |
May 19, 12:33
BridgeBio Pharma Shareholders Equity (Quarterly) : -2.278B for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Mirum Pharmaceuticals, Inc. | 242.49M |
| Pfizer Inc. | 90.10B |
| Insmed, Inc. | 704.85M |
| Alnylam Pharmaceuticals, Inc. | 1.075B |
| Vanda Pharmaceuticals, Inc. | 280.76M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.371B |
| Total Liabilities (Quarterly) | 3.640B |
| Debt to Equity Ratio | -1.486 |
| Current Ratio | 1.520 |
| Net Debt Paydown Yield | -1.62% |